AI assistant
CME GROUP INC. — Director's Dealing 2016
Dec 1, 2016
29871_dirs_2016-12-01_c7c1cb66-de94-466a-ba3b-1bc80d5a4737.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CME GROUP INC. (CME)
CIK: 0001156375
Period of Report: 2016-11-30
Reporting Person: Durkin Bryan T (President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-11-30 | Common Stock Class A | M | 15000 | $54.3 | Acquired | 68680 | Direct |
| 2016-11-30 | Common Stock Class A | S | 15000 | $112.849 | Disposed | 53680 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-11-30 | Non-Qualified Stock Option (right to buy) | $54.3 | M | 15000 | Disposed | 2020-09-15 | Common Stock Class A (15000) | Direct |
Footnotes
F1: This sale was completed pursuant to the terms of a pre-arranged trading plan established in accordance with Rule 10b5-1.
F2: On November 30, 2016, Mr. Durkin sold an aggregate of 15,000 shares of CME Group Class A common stock. For reporting purposes, the sales prices within a $1 range have been aggregated and the weighted average sales price has been reported. The price ranges were: $112.67 to $112.98 and $113.00 to $113.29. The Company maintains a record of the transactions and copies will be provided upon request.
F3: On September 15, 2014, these options vested with respect to 100% of the granted number of shares covered by the option.